Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy
Authors
Keywords
Medicare, Androgen deprivation therapy, Bisphosphonates, Bone mineral density, Prostate cancer
Journal
SUPPORTIVE CARE IN CANCER
Volume 22, Issue 2, Pages 537-544
Publisher
Springer Nature
Online
2013-10-21
DOI
10.1007/s00520-013-2008-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Fracture Prevention in Men Who Receive Androgen Deprivation Therapy for Localized Prostate Cancer
- (2013) Kouta Ito ANNALS OF INTERNAL MEDICINE
- A crosstalk between bone and gonads
- (2012) Franck Oury Annals of the New York Academy of Sciences
- Screening for Osteoporosis in Men Receiving Androgen Deprivation Therapy
- (2012) Shabbir M. H. Alibhai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fracture risk in men with prostate cancer: A population-based study
- (2011) L Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer
- (2011) Philip J. Saylor et al. JOURNAL OF UROLOGY
- Lateral Spine Radiographs Before Androgen Deprivation Treatment Detect a High Incidence of Undiagnosed Vertebral Fragility Fractures in Men With Advanced Prostate Cancer
- (2011) R. Mistry et al. JOURNAL OF UROLOGY
- Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States
- (2011) Jennifer L. Beebe-Dimmer et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Bone health management in prostate cancer patients receiving androgen deprivation therapy
- (2011) Vishnuprabha Dhanapal et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer
- (2011) Mariela Varsavsky et al. Endocrinologia y Nutricion
- Changes in bone health and skeletal-related events following implementation of a multidisciplinary consensus statement guiding surveillance and treatment of men undergoing androgen deprivation therapy for prostate cancer
- (2010) Dayne Matthew Nelson et al. Aging Male
- Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer
- (2010) Pamela Taxel et al. BJU INTERNATIONAL
- Use of a clinical decision support system to increase osteoporosis screening
- (2010) Ramona S. DeJesus et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Application of a Fracture Risk Algorithm to Men Treated With Androgen Deprivation Therapy for Prostate Cancer
- (2010) Philip J. Saylor et al. JOURNAL OF UROLOGY
- A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma
- (2010) Ary Serpa Neto et al. BMC Urology
- Androgen Action in Prostate Cancer
- (2010) Sujit Basu et al. Hormones & Cancer
- Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis
- (2009) Jacques Planas et al. BJU INTERNATIONAL
- Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer
- (2009) Abbas H. Panju et al. BJU INTERNATIONAL
- Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinoma
- (2009) Takefumi Satoh et al. CANCER
- Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer
- (2009) Lockwood G. Taylor et al. CANCER
- Implementation of Osteoporosis Screening Guidelines in Prostate Cancer Patients on Androgen Ablation
- (2009) Lindsay S. Van Tongeren et al. JOURNAL OF CLINICAL DENSITOMETRY
- Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
- (2009) Nirmala Bhoopalam et al. JOURNAL OF UROLOGY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program*
- (2009) Karynsa Cetin et al. UROLOGY
- Incidence and risk factors for low trauma fractures in men with prostate cancer
- (2008) Henrik G. Ahlborg et al. BONE
- Skeletal Health After Continuation, Withdrawal, or Delay of Alendronate in Men With Prostate Cancer Undergoing Androgen-Deprivation Therapy
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer
- (2008) Fred Saad et al. JOURNAL OF CLINICAL ONCOLOGY
- The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States
- (2008) J. R. Curtis et al. OSTEOPOROSIS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started